Grayhack J T, Sensibar J A, Ilio K Y, Kasjanski R Z, Kozlowski J M, Lee C
Department of Urology, Northwestern University Medical School Chicago, Illinois 60611, USA.
J Urol. 1998 Jun;159(6):2202-9. doi: 10.1016/S0022-5347(01)63306-8.
Our goal is to understand human prostate growth phenomena potentially important to BPH development and growth. The objective of the present study is to characterize in vitro prostate stromal proliferative factors in testis epididymal secretions.
Human spermatocele fluids were used as a source of testicular epididymal plasma (STEP). Primary cultures of human prostate stromal cells were routinely grown in RPMI-1640 with 10% fetal bovine serum. During a 6-day experimental period, cells were cultured in RPMI-1640 in the absence of serum but supplemented with ITS. Whole STEP, ether stripped STEP, or heparin affinity column treated STEP was included in the culture medium with and without the addition of testosterone (T), dihydrotestosterone (DHT), or estradiol (E). Results of these treatments were assessed by cell counts. Antibodies against smooth muscle myosin heavy chain, smooth muscle alpha actin, and prolyl-4-hydroxylase were utilized in immunocytochemical characterization of cultured cells.
Whole STEP stimulated prostatic stromal cells derived from prostates of 15, 45, 70 and 72-year-old men. Treatment of STEP by ether stripping or heparin affinity column exposure did not result in a significant reduction in cell counts. With the exception of the 15-year-old specimen, addition of T or DHT to ether stripped STEP resulted in a significant increase in cell counts over that of ether stripped STEP treatment alone. Preliminary immunocytochemical evaluation indicated the presence of variable mixture of fibroblasts, myofibroblasts, and smooth muscle cells in these cultures.
These in vitro observations indicate that testis epididymal secretions contain androgen/STEP synergistic and androgen independent STEP factors promoting prostate stromal growth. These factors are not heparin binding. These observations are consistent with the concept that, in addition to the production of steroids, the testis produces non-androgenic factors that act in concert with, as well as independently of, androgen to stimulate prostatic growth.
我们的目标是了解对良性前列腺增生(BPH)发展和生长可能具有重要意义的人类前列腺生长现象。本研究的目的是对睾丸附睾分泌物中的体外前列腺基质增殖因子进行表征。
人精液囊肿液被用作睾丸附睾血浆(STEP)的来源。人前列腺基质细胞的原代培养物常规在含有10%胎牛血清的RPMI-1640培养基中生长。在为期6天的实验期内,细胞在不含血清但添加了ITS的RPMI-1640培养基中培养。全STEP、经乙醚萃取的STEP或经肝素亲和柱处理的STEP被添加到培养基中,同时添加或不添加睾酮(T)、双氢睾酮(DHT)或雌二醇(E)。通过细胞计数评估这些处理的结果。利用抗平滑肌肌球蛋白重链、平滑肌α肌动蛋白和脯氨酰-4-羟化酶的抗体对培养细胞进行免疫细胞化学表征。
全STEP刺激了来自15岁、45岁、70岁和72岁男性前列腺的基质细胞。通过乙醚萃取或肝素亲和柱处理STEP并没有导致细胞计数显著减少。除了15岁的样本外,向经乙醚萃取的STEP中添加T或DHT导致细胞计数比单独的经乙醚萃取的STEP处理有显著增加。初步免疫细胞化学评估表明这些培养物中存在成纤维细胞、肌成纤维细胞和平滑肌细胞的可变混合物。
这些体外观察结果表明,睾丸附睾分泌物含有促进前列腺基质生长的雄激素/STEP协同因子和雄激素非依赖性STEP因子。这些因子不与肝素结合。这些观察结果与以下概念一致,即除了产生类固醇外,睾丸还产生与雄激素协同作用以及独立于雄激素作用以刺激前列腺生长的非雄激素因子。